Bold solutions with the

CapacitytoCure

At Poseida Therapeutics, we are boldly developing new solutions to redefine treatment paradigms for life-threatening cancers and genetic diseases. We have designed our genetic engineering technologies to represent the future of innovation in cell and gene therapies, giving new hope to patients.

At Poseida Therapeutics, we are boldly developing new solutions to redefine treatment paradigms for life-threatening cancers and genetic diseases. We have designed our genetic engineering technologies to represent the future of innovation in cell and gene therapies, giving new hope to patients.

r-and-d-day-violator-img

x

A close image of a gloved hand holding an orange cap to a cell culture flask. The flask stands upright with a pipette poised above the opening.
A close image of a gloved hand holding an orange cap to a cell culture flask. The flask stands upright with a pipette poised above the opening.

TECHNOLOGY

A Suite of Differentiated Genetic Engineering Platforms

Our non-viral piggyBac® DNA Delivery System inserts large genetic payloads into the genome. Our Cas-CLOVER™ Site-Specific Gene Editing System can be leveraged to make accurate site-specific deletions, insertions, and knock-ins in multiple cell types.

Video

Thomas G. Martin, M.D., discusses case of reactivation of CAR-T Therapy with a T-Cell Engager in Relapsed Multiple Myeloma

Thomas G. Martin, M.D., discusses case of reactivation of CAR-T Therapy with a T-Cell Engager in Relapsed Multiple Myeloma

marting-vid-thumbv3
Poseida - Cell Type Matters
Poseida - Cell Type Matters

PIPELINE

Cell Type Matters

Our gene editing technologies and delivery platforms allow us to target many different cell types to treat cancer and genetic diseases. By focusing on specific cell populations, we can potentially advance fully allogeneic CAR-T therapies with an early memory phenotype for patients fighting cancer or develop functional cures for rare genetic diseases.